RBR-6t4j85尚未招募2 期
A phase 2, double-blind, randomized, controlled trial of the safety and efficacy of Banisteriopsis caapi versus placebo in patients with Parkinson´s disease
Hospital Universitário Clementino Fraga Filho - UFRJ0 个研究点开始时间: 2018年9月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 50Y 至 70Y（—）
入选标准
- •40 l-dopa treated patients (both genders) with Parkinson’s disease fulfilling the Queen Square Brain Bank Criteria with mild to moderate motor fluctuations will be recruited.
排除标准
- •Demented patients with the Mini Mental Status Examination Score, women of childbearing age and those receiving monoamine oxidase inhibitors or amantidine were excluded.
研究者
相似试验
已完成
2 期
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine.Tetanustetanus and diphtheriaClostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsCorynebacterium InfectionsActinomycetales InfectionsDiphtheriaRPCEC00000059Finlay Institute225
已完成
2 期
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.tetanus and diphtheriaClostridium InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsCorynebacterium InfectionsActinomycetales InfectionsTetanusDiphtheriaRPCEC00000058Finlay Institute300
进行中（未招募）
不适用
A phase II, randomized, double-blind, controlled study to evaluate the immune responses, safety and clinical efficacy of three doses of Neovacs’ TNF-Kinoid in adult patients with rheumatoid arthritis who have relapsed despite anti-TNFa biological therapyMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2009-012041-35-BEeovacs SA48
进行中（未招募）
不适用
A phase II, randomized, double-blind, controlled study to evaluate the immune responses, safety and clinical efficacy of three doses of Neovacs’ TNF-Kinoid in adult patients with rheumatoid arthritis who have relapsed despite anti-TNFa biological therapyMedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid arthritisEUCTR2009-012041-35-BGeovacs SA48
已完成
2 期
A Phase 2 Double -blind, Randomized, Controlled Trial to Assess the Safety and Immunogenicity of 10 mcg HXP-GPOVac Vaccine in Healthy Volunteershealthy adultsphase 2, covid vaccine, clinical trial, HXP-GPOVacTCTR20220819003Government Pharmaceutical Organization, Thailand300